|
original article |
Date |
Title |
Authors All Authors |
1 |
[GO] |
2022―Jun―21 |
Willingness to be vaccinated against COVID-19 is equal in individuals with affective disorders and healthy controls |
Frederike T. Fellendorf, Nina Bonkat, Martina Platzer, Elena Schönthaler, Michaela Ratzenhofer, Susanne A. Bengesser, et al. (+2) Nina Dalkner, Eva Z. Reininghaus |
2 |
[GO] |
2022―Jun―18 |
Long-term antibody response following SPUTNIK V primary vaccination in healthcare workers with and without history of SARS-CoV-2 infection: prospective cohort study from a hospital in Argentina |
A. Gentile, V.E. Castellano, A. Pacchiotti, N. Weinberger, S. Diana Menéndez, M. del Pino, et al. (+3) G. Carciofi, P. Lamy, A.S. Mistchenko |
3 |
[GO] |
2022―Jun―18 |
SARS-CoV-2 Variants and Pregnant Women: A Cause for Concern? |
Joy Onyinyechi Chionuma, Helen Onyeaka, Osmond C. Ekwebelem, Nnabueze Darlington Nnaji |
4 |
[GO] |
2022―Jun―14 |
Understandings and Practices Related to Risk, Immunity and Vaccination During the Delta Variant COVID-19 Outbreak in Australia: An Interview Study |
Deborah Lupton |
5 |
[GO] |
2022―Jun―13 |
COVID-19 Vaccine Hesitancy and Influential Factors among Thai Parents and Guardians to Vaccinate Their Children |
Amornphat Kitro, Wachiranun Sirikul, Ekkamon Dilokkhamaruk, Gowgeat Sumitmoh, Sarisa Pasirayut, Amnart Wongcharoen, et al. (+3) Jinjuta Panumasvivat, Krongporn Ongprasert, Ratana Sapbamrer |
6 |
[GO] |
2022―Jun―08 |
Anti-spike protein antibody responses to BNT162b2 mRNA vaccine: a single-center survey in a COVID-19 non-epidemic area in Japan |
Sho Mokuda, Namiki Kawanishi, Shintaro Kuroshima, Junko Kono, Hirofumi Nakayama, Hiroshi Mieno, Masashi Kawamoto |
7 |
[GO] |
2022―Jun―07 |
Knowledge about COVID-19 and vaccine acceptability among priority groups defined for vaccination: a Cross-sectional study in Araba/Alava, Spain, before the vaccination against SARS-CoV-2 |
Naiara Parraza-Diez, Cristina Bermudez-Ampudia, Raquel Cobos-Campos, Ines Garmendia, Estibalitz Orruño, Elena Ojeda, et al. (+4) Ignacio Garitano, María Robledo, Joseba Portu, Antxon Apiñaniz |
8 |
[GO] |
2022―Jun―07 |
SARS-CoV-2 Antibody response after BNT162b2 mRNA vaccine in healthcare workers: nine-month of follow-up |
Franco Mastroianni, Pietro Guida, Grazia Bellanova, Edy Valentina De Nicolò, Giulia Righetti, Maurizio Formoso, Fabrizio Celani |
9 |
[GO] |
2022―May―31 |
Vaccination policies for healthcare personnel in the COVID-19 era: current challenges and future perspectives |
Helena C. Maltezou, George Dounias, Venerando Rapisarda, Caterina Ledda |
10 |
[GO] |
2022―May―18 |
COVID-19 vaccine acceptance and its determinants: a cross-sectional study among the socioeconomically disadvantaged communities living in Delhi, India |
Yadlapalli S. Kusuma, Shashi Kant |
11 |
[GO] |
2022―May―02 |
Pre-existing T cell immunity determines the frequency and magnitude of cellular immune response to two doses of mRNA vaccine against SARS-CoV-2 |
José L Casado, Pilar Vizcarra, Johannes Haemmerle, Héctor Velasco, Adrián Martín-Hondarza, Mario J. Rodríguez-Domínguez, et al. (+5) Tamara Velasco, Sara Martín, Beatriz Romero-Hernández, Marina Fernández-Escribano, Alejandro Vallejo |
12 |
[GO] |
2022―Apr―29 |
Predicting COVID-19 Vaccine Hesitancy in Hong Kong: Vaccine Knowledge, Risks from Coronavirus, and Risks and Benefits of Vaccination |
Stephanie Jean Tsang |
13 |
[GO] |
2022―Apr―23 |
COVID-19 Vaccine Hesitancy and Intent in California Registered Nurses |
Linda Vuong, Julie T. Bidwell, Ester Carolina Apesoa-Varano, Fawn A. Cothran, Sheryl L. Catz |
14 |
[GO] |
2022―Mar―19 |
Impact of covid-19 pandemic on vaccination against meningococcal C infection in Brazil |
Thales Philipe Rodrigues da Silva, Leyla Gabriela Verner Amaral Brandão, Ed Wilson Rodrigues Vieira, Thalita Beatriz Santos Maciel, Tércia Moreira Ribeiro da Silva, Bianca Maria Oliveira Luvisaro, et al. (+2) Fabiana Ramos de Menezes, Fernanda Penido Matozinhos |
15 |
[GO] |
2022―Mar―19 |
“Get a shot of rhythm and blues”: songs on Corona and COVID-19 vaccination |
Ger T. Rijkers, Olivier Braas |
16 |
[GO] |
2022―Mar―11 |
Global interest in vaccines during the COVID-19 pandemic: evidence from Google Trends |
Aida Khakimova, Leila abdollahi, Oleg Zolotarev, Rahim Fakher |
17 |
[GO] |
2022―Mar―08 |
Low Prevalence of COVID-19 Vaccine Hesitancy in Students Across Health Science Disciplines in Texas |
Meredith G. Hosek, Autumn B. Chidester, Jonathan Gelfond, Barbara S. Taylor |
18 |
[GO] |
2022―Mar―05 |
Comparison of Safety and Immunogenicity of CoronaVac and ChAdOx1 Against the SARS-CoV-2 Circulating Variants of Concern (Alpha, Delta, Beta) in Thai Healthcare Workers |
Nasikarn Angkasekwinai, Jaturong Sewatanon, Suvimol Niyomnaitham, Supaporn Phumiamorn, Kasama Sukapirom, Sompong Sapsutthipas, et al. (+6) Rujipas Sirijatuphat, Orasri Wittawatmongkol, Sansnee Senawong, Surakameth Mahasirimongkol, Sakalin Trisiriwanich, Kulkanya Chokephaibulkit |
19 |
[GO] |
2022―Feb―25 |
COVID-19 susceptibility and vaccination coverage for measles, rubella and mumps in students and healthcare workers in Trieste Hospitals (NE Italy) |
Eleonora Cattaruzza, Lucia Radillo, Federico Ronchese, Corrado Negro, Francesca Rui, Paola De Michieli, Francesca Larese Filon |
20 |
[GO] |
2022―Feb―24 |
COVID-19 and cancelled vaccination programs: Forecasting outbreaks of vaccine preventable diseases (VPDs) in Pakistan |
Inayat Ali |
21 |
[GO] |
2022―Feb―19 |
Barriers and facilitators to COVID-19 vaccine acceptability among people incarcerated in Canadian federal prisons: A qualitative study |
David Lessard, David Ortiz-Paredes, Hyejin Park, Olivia Varsaneux, James Worthington, Nicole E. Basta, et al. (+5) Shannon E. MacDonald, Bertrand Lebouché, Joseph Cox, Shainoor J. Ismail, Nadine Kronfli |
22 |
[GO] |
2022―Jan―31 |
Medical Factors Associated with Caregiver Intention to Vaccinate their Children Against COVID-19 |
Thao-Ly T. Phan, Paul T. Enlow, Michael K. Wong, Amanda M. Lewis, Anne E. Kazak, Jonathan M. Miller |
23 |
[GO] |
2022―Jan―05 |
Explaining the intention to uptake COVID-19 vaccination using the Behavioral and Social Drivers of Vaccination (BeSD) model |
Subburaj Alagarsamy, Sangeeta Mehrolia, Ushanandini Pushparaj, S Jeevananda |
24 |
[GO] |
2021―Dec―28 |
Cov19VaxKB: A Web-based Integrative COVID-19 Vaccine Knowledge Base |
Philip C. Huang, Rohit Goru, Anthony Huffman, Asiyah Yu Lin, Michael F. Cooke, Yongqun He |
25 |
[GO] |
2021―Dec―22 |
Reduced COVID-19 Hospitalizations among New York City Residents Following Age-Based SARS-CoV-2 Vaccine Eligibility: Evidence from a Regression Discontinuity Design |
Sharon K. Greene, Alison Levin-Rector, Emily McGibbon, Jennifer Baumgartner, Katelynn Devinney, Alexandra Ternier, et al. (+3) Jessica Sell, Rebecca Kahn, Nishant Kishore |
26 |
[GO] |
2021―Nov―05 |
Recombinant protein subunit SARS-CoV-2 vaccines formulated with CoVaccine HT adjuvant induce broad, Th1 biased, humoral and cellular immune responses in mice |
Chih-Yun Lai, Albert To, Teri Ann S. Wong, Michael M. Lieberman, David E. Clements, James T. Senda, et al. (+7) Aquena H. Ball, Laurent Pessaint, Hanne Andersen, Wakako Furuyama, Andrea Marzi, Oreola Donini, Axel T. Lehrer |
27 |
[GO] |
2021―Nov―03 |
Appendicitis as a possible safety signal for the COVID-19 vaccines |
Joseph Mitchell, Qun-Ying Yue |
28 |
[GO] |
2021―Oct―22 |
To be or not to be vaccinated against COVID-19 - The adolescents’ perspective - A mixed-methods study in Sweden |
S. Nilsson, J. Mattson, M. Berghammer, A-L. Brorsson, M. Forsner, M. Jenholt Nolbris, et al. (+7) I. Kull, A. Lindholm Olinder, S. Ragnarsson, A-C. Rullander, L-L. Rydström, M. Andréia Garcia de Avila, P. Olaya-Contreras |
29 |
[GO] |
2021―Sep―08 |
The successful COVID-19 vaccine rollout in Chile: factors and challenges |
Claudio Castillo, Pablo Villalobos Dintrans, Matilde Maddaleno |
30 |
[GO] |
2021―Sep―03 |
COVID-19 vaccine hesitancy and willingness to pay: Emergent factors from a cross-sectional study in Nigeria |
Obi Peter Adigwe |
31 |
[GO] |
2021―Jul―15 |
Willingness to vaccinate against Covid-19: A qualitative study involving older adults from Southern Switzerland |
Marta Fadda, L. Suzanne Suggs, Emiliano Albanese |
32 |
[GO] |
2021―Jun―29 |
Intentions of Public School Teachers in British Columbia, Canada to Receive a COVID-19 Vaccine |
C. Sarai Racey, Robine Donken, Imogen Porter, Arianne Albert, Julie A. Bettinger, Jennifer Mark, et al. (+9) Lizl Bonifacio, Meena Dawar, Mike Gagel, Rakel Kling, Silvina Mema, Hana Mitchell, Ian Roe, Gina Ogilvie, Manish Sadarangani |
33 |
[GO] |
2021―Apr―24 |
Unbiased interrogation of memory B cells from convalescent COVID-19 patients reveals a broad antiviral humoral response targeting SARS-CoV-2 antigens beyond the spike protein |
Jillian M. DiMuzio, Baron C. Heimbach, Raymond J. Howanski, John P. Dowling, Nirja B. Patel, Noeleya Henriquez, et al. (+9) Chris Nicolescu, Mitchell Nath, Antonio Polley, Jamie L. Bingaman, Todd Smith, Benjamin C. Harman, Matthew K. Robinson, Michael J. Morin, Pavel A. Nikitin |
34 |
[GO] |
2021―Apr―20 |
Seasonal Influenza Vaccination Policies in the 194 WHO Member States: the evolution of global influenza pandemic preparedness and the challenge of sustaining equitable vaccine access |
Kathleen F. Morales, David W. Brown, Laure Dumolard, Claudia Steulet, Alba Vilajeliu, Alba Maria Ropero Alvarez, et al. (+3) Ann Moen, Martin Friede, Philipp Lambach |
35 |
[GO] |
2021―Apr―01 |
Cancelled routine vaccination appointments due to COVID-19 pandemic in Germany |
Nora Katharina Schmid-Küpke, Dorothea Matysiak-Klose, Anette Siedler, Lisa Felgendreff, Lothar Wieler, Heidrun M. Thaiss, Cornelia Betsch |
36 |
[GO] |
2021―Mar―23 |
Demographic, psychological, and experiential correlates of SARS-CoV-2 vaccination intentions in a sample of Canadian families |
Christine L. Lackner, Charles H. Wang |
37 |
[GO] |
2021―Jan―12 |
Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: an example using rotavirus vaccines applied to SARS-CoV-2 |
T Christopher Mast, David Heyman, Erik Dasbach, Craig Roberts, Michelle Goveia, Lyn Finelli |
38 |
[GO] |
2020―Aug―28 |
What are the roles of antibodies versus a durable, high quality T-cell response in protective immunity against SARS-CoV2? |
Marc Hellerstein |